Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myeloma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-8722
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myeloma ; volume:12 ; number:1 ; day:21 ; month:3 ; year:2019 ; pages:1-17 ; date:12.2019
Journal of hematology & oncology ; 12, Heft 1 (21.3.2019), 1-17, 12.2019
- Urheber
-
Cucè, Maria
Gallo Cantafio, Maria Eugenia
Siciliano, Maria Anna
Riillo, Caterina
Caracciolo, Daniele
Scionti, Francesca
Staropoli, Nicoletta
Zuccalà, Valeria
Maltese, Lorenza
Di Vito, Anna
Grillone, Katia
Barbieri, Vito
Arbitrio, Mariamena
Di Martino, Maria Teresa
Rossi, Marco
Amodio, Nicola
Tagliaferri, Pierosandro
Tassone, Pierfrancesco
Botta, Cirino
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13045-019-0714-9
- URN
-
urn:nbn:de:101:1-2019050200015609173291
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Cucè, Maria
- Gallo Cantafio, Maria Eugenia
- Siciliano, Maria Anna
- Riillo, Caterina
- Caracciolo, Daniele
- Scionti, Francesca
- Staropoli, Nicoletta
- Zuccalà, Valeria
- Maltese, Lorenza
- Di Vito, Anna
- Grillone, Katia
- Barbieri, Vito
- Arbitrio, Mariamena
- Di Martino, Maria Teresa
- Rossi, Marco
- Amodio, Nicola
- Tagliaferri, Pierosandro
- Tassone, Pierfrancesco
- Botta, Cirino
- SpringerLink (Online service)
Ähnliche Objekte (12)
Impact of the NK Cell Receptor LIR-1 (ILT-2/CD85j/LILRB1) on Cytotoxicity against Multiple Myeloma
CRISPR-Cas9 based gene editing of the immune checkpoint NKG2A enhances NK cell mediated cytotoxicity against multiple myeloma
P24. Aviscumine enhances NK- cytotoxicity against tumor cells
Enhancing the Activation and Releasing the Brakes: A Double Hit Strategy to Improve NK Cell Cytotoxicity Against Multiple Myeloma
Enhancing the activation and releasing the brakes : a double hit strategy to improve NK cell cytotoxicity against multiple myeloma
TLR9 agonism differentially impacts human NK cell-mediated direct killing and antibody-dependent cell-mediated cytotoxicity
Progranulin Prevents Regulatory NK Cell Cytotoxicity Against Antiviral T Cells
STAT1 signaling shields T cells from NK cell-mediated cytotoxicity
Mouse TIGIT inhibits NK ‐cell cytotoxicity upon interaction with PVR
Cereblon regulates NK cell cytotoxicity and migration via Rac1 activation
Icaritin induces lytic cytotoxicity in extranodal NK/T-cell lymphoma
Ex-vivo expanded human NK cells mediate cytotoxicity and cytokine release against allogeneic cancer cell line by direct recognition and antibody directed cellular cytotoxicity: therapeutic potential use of NK cells for blood and solid tumors
Impact of the NK Cell Receptor LIR-1 (ILT-2/CD85j/LILRB1) on Cytotoxicity against Multiple Myeloma
CRISPR-Cas9 based gene editing of the immune checkpoint NKG2A enhances NK cell mediated cytotoxicity against multiple myeloma
P24. Aviscumine enhances NK- cytotoxicity against tumor cells
Enhancing the Activation and Releasing the Brakes: A Double Hit Strategy to Improve NK Cell Cytotoxicity Against Multiple Myeloma
Enhancing the activation and releasing the brakes : a double hit strategy to improve NK cell cytotoxicity against multiple myeloma
TLR9 agonism differentially impacts human NK cell-mediated direct killing and antibody-dependent cell-mediated cytotoxicity
Progranulin Prevents Regulatory NK Cell Cytotoxicity Against Antiviral T Cells
STAT1 signaling shields T cells from NK cell-mediated cytotoxicity
Mouse TIGIT inhibits NK ‐cell cytotoxicity upon interaction with PVR
Cereblon regulates NK cell cytotoxicity and migration via Rac1 activation
Icaritin induces lytic cytotoxicity in extranodal NK/T-cell lymphoma
Ex-vivo expanded human NK cells mediate cytotoxicity and cytokine release against allogeneic cancer cell line by direct recognition and antibody directed cellular cytotoxicity: therapeutic potential use of NK cells for blood and solid tumors
Impact of the NK Cell Receptor LIR-1 (ILT-2/CD85j/LILRB1) on Cytotoxicity against Multiple Myeloma
CRISPR-Cas9 based gene editing of the immune checkpoint NKG2A enhances NK cell mediated cytotoxicity against multiple myeloma
P24. Aviscumine enhances NK- cytotoxicity against tumor cells
Enhancing the Activation and Releasing the Brakes: A Double Hit Strategy to Improve NK Cell Cytotoxicity Against Multiple Myeloma
Enhancing the activation and releasing the brakes : a double hit strategy to improve NK cell cytotoxicity against multiple myeloma
TLR9 agonism differentially impacts human NK cell-mediated direct killing and antibody-dependent cell-mediated cytotoxicity
Progranulin Prevents Regulatory NK Cell Cytotoxicity Against Antiviral T Cells
STAT1 signaling shields T cells from NK cell-mediated cytotoxicity
Mouse TIGIT inhibits NK ‐cell cytotoxicity upon interaction with PVR
Cereblon regulates NK cell cytotoxicity and migration via Rac1 activation
Icaritin induces lytic cytotoxicity in extranodal NK/T-cell lymphoma